187 related articles for article (PubMed ID: 23897439)
21. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
22. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
23. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
Wang S; Fan W; Kim G; Hah HJ; Lee YE; Kopelman R; Ethirajan M; Gupta A; Goswami LN; Pera P; Morgan J; Pandey RK
Lasers Surg Med; 2011 Sep; 43(7):686-95. PubMed ID: 22057496
[TBL] [Abstract][Full Text] [Related]
24. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Ferrario A; Fisher AM; Rucker N; Gomer CJ
Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
[TBL] [Abstract][Full Text] [Related]
25. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors.
Cecic I; Korbelik M
Cancer Lett; 2002 Sep; 183(1):43-51. PubMed ID: 12049813
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1alpha.
Mitra S; Cassar SE; Niles DJ; Puskas JA; Frelinger JG; Foster TH
Mol Cancer Ther; 2006 Dec; 5(12):3268-74. PubMed ID: 17172430
[TBL] [Abstract][Full Text] [Related]
27. The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.
Korbelik M; Naraparaju VR; Yamamoto N
Br J Cancer; 1998 Mar; 77(6):1009-14. PubMed ID: 9528849
[TBL] [Abstract][Full Text] [Related]
28. A fluorescence-activatable tumor-reporting probe for precise photodynamic therapy.
Li J; Wang T; Jiang F; Hong Z; Su X; Li S; Han S
J Mater Chem B; 2021 Jul; 9(29):5829-5836. PubMed ID: 34254096
[TBL] [Abstract][Full Text] [Related]
29. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
[TBL] [Abstract][Full Text] [Related]
30. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
[TBL] [Abstract][Full Text] [Related]
31. IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Brackett CM; Owczarczak B; Ramsey K; Maier PG; Gollnick SO
Lasers Surg Med; 2011 Sep; 43(7):676-85. PubMed ID: 22057495
[TBL] [Abstract][Full Text] [Related]
32. Whole body and local hyperthermia enhances the photosensitizing efficacy of 3-[(1'-hexyloxy)ethyl]-3-Devinylpyropheophorbide-a (HPPH).
Srivatsan A; Sen A; Cheruku RR; Missert JR; Durrani FA; Guru K; Pandey RK
Lasers Surg Med; 2018 Jul; 50(5):506-512. PubMed ID: 29737551
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
34. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy and anti-tumor immunity.
Gollnick SO; Owczarczak B; Maier P
Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik M; Dougherty GJ
Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
[TBL] [Abstract][Full Text] [Related]
37. Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles.
Gupta A; Wang S; Pera P; Rao KV; Patel N; Ohulchanskyy TY; Missert J; Morgan J; Koo-Lee YE; Kopelman R; Pandey RK
Nanomedicine; 2012 Aug; 8(6):941-50. PubMed ID: 22115602
[TBL] [Abstract][Full Text] [Related]
38. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
39. Imaging a photodynamic therapy photosensitizer in vivo with a time-gated fluorescence tomography system.
Mo W; Rohrbach D; Sunar U
J Biomed Opt; 2012 Jul; 17(7):071306. PubMed ID: 22894467
[TBL] [Abstract][Full Text] [Related]
40. The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.
Ferrario A; Chantrain CF; von Tiehl K; Buckley S; Rucker N; Shalinsky DR; Shimada H; DeClerck YA; Gomer CJ
Cancer Res; 2004 Apr; 64(7):2328-32. PubMed ID: 15059880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
